Early Gastrointestinal Cancers

Clinically relevant study end points in rectal cancer.- Neoadjuvant treatment in rectal cancer: Do we always need radiotherapy?- Treatment dilemmas in patients with synchronous colorectal liver metastases.- Pancreatic surgery: beyond the traditional limits.- Adjuvant therapy for pancreatic cancer.- Radiotherapy of the pancreas: state of the art in 2012.- Adenocarcinoma of the GEJ: gastric or oesophageal cancer?- Why is there a change in patterns of GE cancer?- Open or minimally invasive resection for oesophageal cancer?- Criteria for selecting the best multimodal therapy.- When is the definitive radiochemotherapy the treatment of choice?- Radiotherapy of gastroesophageal junction (GEJ) cancer.- Optimizing neoadjuvant chemotherapy through the use of early response evaluation by PET .- Optimal surgery for gastric cancer: is more always better?- Can adjuvant chemoradiotherapy replace extended lymph node dissection in gastric cancer?- Predicting the response to chemotherapy in gastric adenocarcinoma: who benefits from neoadjuvant chemotherapy?- Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.- Selecting the best treatment for an individual patient.

From the reviews:

"This is an up-to-date, scientifically reviewed summary of current treatment options for select GI cancers. Each section stands independently and is well presented, yet brief. ... It is written for clinicians or researchers focusing on clinical cancer treatment. Surgical, medical, and radiation providers will benefit from the topics and presentations. ... The table of contents is a very easy way to identify select sections to address specific situations. ... The literature cited is international and includes both Eastern and Western points of view." (Neal Wilkinson, Doody's Review Service, February, 2013)